{"id":210056,"name":"ORCHARD THERAPEUTICS NORTH AMERICA","slug":"orchard-therapeutics-north-america","state":"MA","country":"United States of America","description":"Gene Therapy Company","totalSpending":750000,"filings":13,"yearlySpending":[{"year":2021,"income":170000},{"year":2022,"income":280000},{"year":2023,"income":260000},{"year":2024,"income":40000}],"issues":[{"code":"HCR","display":"Health Issues"},{"code":"MMM","display":"Medicare/Medicaid"},{"code":"BUD","display":"Budget/Appropriations"}],"firms":["THE MCMANUS GROUP"],"lobbyists":["JOHN MCMANUS","ALANNA TEMME","LAWREN GEER"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE"],"sampleDescriptions":["Issues related to gene therapies for rare diseases.","Education and awareness of rare and ultra rare diseases and patient access to orphan drugs.","Access and coverage of pharmaceuticals in Medicaid program.\n\nEducation and awareness of rare and ultra rare diseases and patient access to orphan drugs.","Education and awareness of rare and ultra rare diseases and patient access to orphan drugs.","Access and coverage of inpatient drugs in Medicaid program.\n\nEducation and awareness of rare and ultra rare diseases and patient access to orphan drugs."]}